卡维地洛是近几年合成的一种新型的第三代β-受体阻滞剂[1],目前在国内临床应用中有国产的(齐鲁制药厂,商品名金络)及进口的(罗氏制药公司,商品名达利全)两种产品。充血性心力衰竭(CHF)的发生、发展过程中,体内许多代偿机制被激活,以期维持机体循环功能。这些代偿机制主要包括 Carvedilol is a new type of third-generation β-blocker synthesized in recent years [1]. At present, there are domestic-made (Qilu Pharmaceutical Factory, trade name Golden Network) and imported (Roche Pharmaceuticals, trade name Daly full) two products. During the development of congestive heart failure (CHF), many compensatory mechanisms in the body are activated in order to maintain the circulatory function of the body. These compensation mechanisms mainly include